Source:http://linkedlifedata.com/resource/pubmed/id/10027846
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-4-1
|
pubmed:abstractText |
LEK-8829 [9,10-didehydro-N-methyl-(2-propynyl)-6-methyl-8- aminomethylergoline bimaleinate] is an antagonist of dopamine D2 receptors and serotonin (5-HT)2 and 5-HT1A receptors in intact animals and a D1 receptor agonist in dopamine-depleted animals. In the present study, we used rats with unilateral striatal lesions with ibotenic acid (IA) to investigate the dopamine receptor activities of LEK-8829 in a model with innervated dopamine receptors. The IA-lesioned rats circled ipsilaterally when challenged with apomorphine, the mixed agonist on D1/D2 receptors. LEK-8829 induced a dose-dependent contralateral turning that was blocked by D1 receptor antagonist SCH-23390. The treatment with D1 receptor agonist SKF-82958 induced ipsilateral turning, whereas the treatment with D2 receptor antagonist haloperidol induced contralateral posture. The combined treatment with SKF-82958 and haloperidol resulted in a weak contralateral turning, indicating the possible receptor mechanism of contralateral turning induced by LEK-8829. Bromocriptine induced a weak ipsilateral turning that was blocked by haloperidol. The ipsilateral turning induced by bromocriptine was significantly potentiated by the coadministration of a low dose but not by a high dose of LEK-8829. The potentiation of turning was blocked either by SCH-23390 or by haloperidol. The potentiation of ipsilateral turning suggests the costimulation of D2 and D1 receptors by bromocriptine and LEK-8829, respectively, whereas the lack of potentiation by the highest dose of LEK-8829 may be explained by the opposing activity of LEK-8829 and bromocriptine at D2 receptors. We propose that the D2 and 5HT2 receptor-blocking and D1 receptor-stimulating profile of LEK-8829 is promising for the treatment of negative symptoms of schizophrenia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Benzazepines,
http://linkedlifedata.com/resource/pubmed/chemical/Bromocriptine,
http://linkedlifedata.com/resource/pubmed/chemical/Excitatory Amino Acid Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Haloperidol,
http://linkedlifedata.com/resource/pubmed/chemical/Ibotenic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/LEK 8829,
http://linkedlifedata.com/resource/pubmed/chemical/Lysergic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine,
http://linkedlifedata.com/resource/pubmed/chemical/SK&F 82958
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-3565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
288
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1093-100
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:10027846-Animals,
pubmed-meshheading:10027846-Antipsychotic Agents,
pubmed-meshheading:10027846-Behavior, Animal,
pubmed-meshheading:10027846-Benzazepines,
pubmed-meshheading:10027846-Bromocriptine,
pubmed-meshheading:10027846-Corpus Striatum,
pubmed-meshheading:10027846-Dose-Response Relationship, Drug,
pubmed-meshheading:10027846-Drug Interactions,
pubmed-meshheading:10027846-Excitatory Amino Acid Agonists,
pubmed-meshheading:10027846-Haloperidol,
pubmed-meshheading:10027846-Ibotenic Acid,
pubmed-meshheading:10027846-Lysergic Acid,
pubmed-meshheading:10027846-Male,
pubmed-meshheading:10027846-Rats,
pubmed-meshheading:10027846-Rats, Wistar,
pubmed-meshheading:10027846-Receptors, Dopamine,
pubmed-meshheading:10027846-Rotation
|
pubmed:year |
1999
|
pubmed:articleTitle |
Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
|
pubmed:affiliation |
University of Ljubljana, School of Medicine, Institute of Pathophysiology, Ljubljana, Slovenia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|